resorufin has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fry, NL; Hinck, L; Marlow, R; Mascharak, PK; Rose, MJ | 1 |
| Fry, NL; Heilman, BJ; Mascharak, PK | 1 |
| Harimoto, N; Hashimoto, I; Ijima, H; Kawabata, K; Kawakami, K; Mu, C; Sakai, S; Salmons, B; Tanaka, S | 1 |
3 other study(ies) available for resorufin and Neoplasms
| Article | Year |
|---|---|
Sensitization of ruthenium nitrosyls to visible light via direct coordination of the dye resorufin: trackable NO donors for light-triggered NO delivery to cellular targets.
Topics: Cell Line, Tumor; Fluorescent Dyes; Humans; Light; Neoplasms; Nitric Oxide; Nitric Oxide Donors; Organometallic Compounds; Oxazines; Photochemotherapy; Photolysis; Ruthenium; Skin Neoplasms | 2008 |
Dye-tethered ruthenium nitrosyls containing planar dicarboxamide tetradentate N4 ligands: effects of in-plane ligand twist on NO photolability.
Topics: Benzene; Crystallography, X-Ray; Fluorescent Dyes; Ligands; Light; Molecular Structure; Molecular Targeted Therapy; Neoplasms; Nitric Oxide; Nitroso Compounds; Oxazines; Photochemistry; Photolysis; Pyridines; Ruthenium | 2011 |
Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biophysics; Cats; Cell Line; Cell Size; Cell Survival; Cytochrome P-450 CYP2B1; Drug Delivery Systems; Humans; Ifosfamide; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Oxazines; Particle Size; Sepharose; Temperature; Time Factors | 2005 |